Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

864 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Two-year serial coronary angiographic and intravascular ultrasound analysis of in-stent angiographic late lumen loss and ultrasonic neointimal volume from the TAXUS II trial.
Tsuchida K, Serruys PW, Bruining N, Dudek D, Drzewiecki J, Banning AP, Zmudka K, Schiele F, Zhou Z, Rademaker TA, van Es GA, Koglin J, Russell ME, Colombo A. Tsuchida K, et al. Am J Cardiol. 2007 Mar 1;99(5):607-15. doi: 10.1016/j.amjcard.2006.09.107. Epub 2007 Jan 9. Am J Cardiol. 2007. PMID: 17317358 Clinical Trial.
Comparison of early outcome of percutaneous coronary intervention for unprotected left main coronary artery disease in the drug-eluting stent era with versus without intravascular ultrasonic guidance.
Agostoni P, Valgimigli M, Van Mieghem CA, Rodriguez-Granillo GA, Aoki J, Ong AT, Tsuchida K, McFadden EP, Ligthart JM, Smits PC, de Jaegere P, Sianos G, Van der Giessen WJ, De Feyter P, Serruys PW. Agostoni P, et al. Among authors: tsuchida k. Am J Cardiol. 2005 Mar 1;95(5):644-7. doi: 10.1016/j.amjcard.2004.10.042. Am J Cardiol. 2005. PMID: 15721110
Distal left main coronary disease is a major predictor of outcome in patients undergoing percutaneous intervention in the drug-eluting stent era: an integrated clinical and angiographic analysis based on the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) and Taxus-Stent Evaluated At Rotterdam Cardiology Hospital (T-SEARCH) registries.
Valgimigli M, Malagutti P, Rodriguez-Granillo GA, Garcia-Garcia HM, Polad J, Tsuchida K, Regar E, Van der Giessen WJ, de Jaegere P, De Feyter P, Serruys PW. Valgimigli M, et al. Among authors: tsuchida k. J Am Coll Cardiol. 2006 Apr 18;47(8):1530-7. doi: 10.1016/j.jacc.2005.11.066. Epub 2006 Mar 27. J Am Coll Cardiol. 2006. PMID: 16630987 Free article.
Three-year clinical follow-up of the unrestricted use of sirolimus-eluting stents as part of the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry.
Daemen J, Ong AT, Stefanini GG, Tsuchida K, Spindler H, Sianos G, de Jaegere PP, van Domburg RT, Serruys PW. Daemen J, et al. Among authors: tsuchida k. Am J Cardiol. 2006 Oct 1;98(7):895-901. doi: 10.1016/j.amjcard.2006.04.031. Epub 2006 Aug 7. Am J Cardiol. 2006. PMID: 16996869
Cyphering the complexity of coronary artery disease using the syntax score to predict clinical outcome in patients with three-vessel lumen obstruction undergoing percutaneous coronary intervention.
Valgimigli M, Serruys PW, Tsuchida K, Vaina S, Morel MA, van den Brand MJ, Colombo A, Morice MC, Dawkins K, de Bruyne B, Kornowski R, de Servi S, Guagliumi G, Jukema JW, Mohr FW, Kappetein AP, Wittebols K, Stoll HP, Boersma E, Parrinello G; ARTS II. Valgimigli M, et al. Among authors: tsuchida k. Am J Cardiol. 2007 Apr 15;99(8):1072-81. doi: 10.1016/j.amjcard.2006.11.062. Epub 2007 Mar 6. Am J Cardiol. 2007. PMID: 17437730 Clinical Trial.
864 results